mebendazole has been researched along with Diabetes Mellitus, Type 2 in 3 studies
Mebendazole: A benzimidazole that acts by interfering with CARBOHYDRATE METABOLISM and inhibiting polymerization of MICROTUBULES.
mebendazole : A carbamate ester that is methyl 1H-benzimidazol-2-ylcarbamate substituted by a benzoyl group at position 5.
Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.
Excerpt | Relevance | Reference |
---|---|---|
"After the observation of decreasing insulin resistance in a diabetic patient during treatment with mebendazole for nematosis, we investigated the effect of mebendazole on metabolic control in six Type 1 (insulin-dependent) and six Type 2 (non-insulin-dependent) diabetic patients, eight of whom were chronically resistant to conventional treatment." | 3.67 | Improvement of metabolic control in diabetic patients during mebendazole administration: preliminary studies. ( Boden, G; Caprio, S; Dayal, VK; Hoeldtke, RD; Mozzoli, MA; Owen, OE; Ray, TK; Reichard, GA; Shuman, CR; Smith, RH, 1984) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Gales, L | 1 |
Forsea, L | 1 |
Mitrea, D | 1 |
Stefanica, I | 1 |
Stanculescu, I | 1 |
Mitrica, R | 1 |
Georgescu, M | 1 |
Trifanescu, O | 1 |
Anghel, R | 1 |
Serbanescu, L | 1 |
Caprio, S | 1 |
Ray, TK | 1 |
Boden, G | 1 |
Reichard, GA | 1 |
Shuman, CR | 1 |
Smith, RH | 1 |
Mozzoli, MA | 1 |
Dayal, VK | 1 |
Hoeldtke, RD | 1 |
Owen, OE | 1 |
Coovadia, YM | 1 |
Rajput, MC | 1 |
Bhana, RH | 1 |
2 reviews available for mebendazole and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Antidiabetics, Anthelmintics, Statins, and Beta-Blockers as Co-Adjuvant Drugs in Cancer Therapy.
Topics: Adenosine Monophosphate; Adrenergic beta-Antagonists; Anthelmintics; Anti-Bacterial Agents; Antihype | 2022 |
Disseminated strongyloidiasis in a diabetic patient.
Topics: Acute Kidney Injury; Animals; Ascitic Fluid; Diabetes Mellitus, Type 2; Fatal Outcome; Feces; Humans | 1993 |
1 other study available for mebendazole and Diabetes Mellitus, Type 2
Article | Year |
---|---|
Improvement of metabolic control in diabetic patients during mebendazole administration: preliminary studies.
Topics: Adult; Benzimidazoles; Blood Glucose; C-Peptide; Chlorpropamide; Diabetes Mellitus, Type 1; Diabetes | 1984 |